ANNX

Conviction 52HealthcareScan · Thu, Jun 25, 2026

ANNX$5.15-2.83%

ResistanceSupportVol 14Insider buy

Vol MA14 3.69M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Annexon, Inc.PHARMACEUTICAL PREPARATIONSwww.annexonbio.com ↗

Price5.15

Change-2.83%

Gap+0.57%

Rel volume2.77×

Avg volume3.48M

Avg $ vol17.8M

SMA 205.10

SMA 505.47

SMA 2004.79

Price vs 50-5.91%

Price vs 200+7.56%

MA stackmixed

50/200 cross—

Supertrenddown · 5.59

RSI (14)50

MACD hist0.06

MACD crossbull · 3d

Stoch %K / %D61 / 65

ADX (14)14

+DI / −DI24 / 18

RSI divergence—

MACD divergence—

ATR %+6.92%

ADR %6.84%

52w high6.96

52w low2.05

From 52w high-26.01%

Above 52w low+151.22%

New 52w highNo

SqueezeOff

Bollinger width23.75%

%B0.54

Donchian pos47.26%

Donchian high5.92

Donchian low4.46

AVWAP (52w high)5.51

vs AVWAP high-6.56%

AVWAP (52w low)4.59

vs AVWAP low+12.22%

OBV trendFlat

Chaikin MF (20)-0.25

Today vs 20d2.77×

Avg vol (14d)3.69M

Avg vol (20d)3.48M

Avg $ vol (20d)17.8M

Market cap198.6M

RS 3m (vs SPY)-6.26%

RS 6m (vs SPY)-5.22%

RS line new highNo

Trend template4/8

Technical rank48.1

1 week+4.25%

1 month-6.70%

3 months-4.01%

6 months-0.77%

1 year+110.20%

YTD+9.81%

P/E-0.96

P/B0.97

P/S—

P/FCF-1.06

EPS-1.34

Div yield—

ROE-101.05%

ROA-78.62%

Debt/Eq—

Current6.35

EV/EBITDA-0.11

Gross margin—

Net margin—

Rev growth—

EPS growth-49.56%

Price target14.00

Target upside171.84%

Analyst ratingBuy

Institutional100.10%

Ent. value23.39M

Revenue—

Net income-44.14M

Gross profit—

Free cash flow-186.49M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out163.84M

Employees93

ListedFri, Jul 24, 2020

Free float86.06M

Float %71.9%

Short interest25.83M

Days to cover9.7d

Short volume69.8%

Squeeze score100 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.23 vs −$0.30

Last surprise+23.3% beat

Setup gradeC

Conviction52 / 100

Pattern quality—

Tech rank48.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.97

Support4.65

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANNX

All disclosures →

No recent disclosed trades by Congress in ANNX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANNX · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Satter Muneer A Director · Common Stock · 2026-05-28	Buy	613.5K	$3.3M	2026-05-28	2026-05-29
Carson William H. Director · Common Stock · 2026-05-11	Buy	8K	$46K	2026-05-11	2026-05-13
Carson William H. Director · Common Stock · 2026-04-10	Buy	8K	$50K	2026-04-10	2026-04-14

SEC filings

EDGAR filings in ANNX · 1 recent

EDGAR →

8-K8-KFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.